// App-Quantinova.ai

: Rifampin Containing Regimen for the Treatment of Active Tuberculosis (TB) in Patients with Rifampin Allergy

Researchers

Presenter

  • J. Batt

Principal Investigators

  • D. Denis

  • G. Regan

  • J. Telchi

  • W. Isaranuwatchai

  • N. Vozoris

Medical Centers

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • Rifampin Injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved